Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Two-Stage, Serial Cohort Dose Escalation and Expansion Study of a Single Intravenous Infusion of HBI 3000 for the Conversion of Atrial Fibrillation (AF) of Recent Onset

NCT04680026 is registered in ClinicalTrials.gov with HUYABIO International, LLC. as lead sponsor.

NCT NCT04680026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04680026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Two-Stage, Serial Cohort Dose Escalation and Expansion Study of a Single Intravenous Infusion of HBI 3000 for the Conversion of Atrial Fibrillation (AF) of Recent Onset
Lead sponsor
HUYABIO International, LLC.
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 1, 2021
Completion date
December 31, 2025
Enrollment
150 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation